Last reviewed · How we verify

NCT06162247

Naples Federico II Intensive Cardiac Care Unit Registry (Naples FED2-ICCU Registry)

Recruiting now Last updated 3 March 2025
What this trial tests

trial in Acute Cardiovascular Disease in 5,000 participants. Currently enrolling.

Timeline
20 November 2023
Primary endpoint
20 November 2033
20 November 2033

Quick facts

Lead sponsorFederico II University
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment5,000
Start date20 November 2023
Primary completion20 November 2033
Estimated completion20 November 2033
Sites1 location across Italy

Conditions studied

Sponsor

Federico II University

Who can join

18 and older, any sex, with Acute Cardiovascular Disease or Acute Coronary Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This protocol proposes to prospectively evaluate current epidemiology, pharmacologic and invasive management and clinical outcomes of patients with acute cardiovascular diseases admitted at our ICCU.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Acute Cardiovascular Disease

Currently open trials in the same condition.

Other Federico II University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06162247.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing